Kai Fu Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2023	Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
1/2023	TRIM24 is critical for the cellular response to DNA double-strand breaks through regulating the recruitment of MRN complex.
12/2015	Glycogen synthase kinase-3β regulates tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis via the NF-κB pathway in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai Fu Research Topics

Disease

65	Neoplasms (Cancer) 03/2024 - 04/2002
21	Lymphoma (Lymphomas) 01/2023 - 06/2005
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2019 - 06/2006
15	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 06/2005
14	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 12/2005
12	Carcinogenesis 01/2022 - 11/2010
10	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2017
8	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 01/2020
8	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2018
6	Infections 02/2023 - 03/2012
6	Lung Neoplasms (Lung Cancer) 05/2020 - 04/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 03/2008
5	Inflammation (Inflammations) 01/2023 - 07/2008
5	Wounds and Injuries (Trauma) 11/2022 - 01/2014
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2010
5	Leukemia 01/2021 - 07/2013
5	Fibrosis (Cirrhosis) 01/2020 - 04/2008
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 08/2011
4	Disease Progression 01/2021 - 01/2012
4	Pain (Aches) 01/2018 - 04/2014
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 11/2014
4	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2015 - 06/2006
3	Adenocarcinoma of Lung 01/2024 - 04/2008
3	Glioma (Gliomas) 04/2023 - 02/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2015
3	Wilms Tumor (Wilm's Tumor) 01/2021 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 06/2013
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 04/2015
3	Contact Dermatitis (Eczema, Contact) 01/2017 - 04/2014
3	Autoimmune Diseases (Autoimmune Disease) 03/2016 - 01/2013
2	Sepsis (Septicemia) 03/2024 - 09/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 01/2023
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 12/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 08/2010
2	Hypospadias 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
2	Adenoma (Adenomas) 11/2021 - 12/2014
2	Critical Illness (Critically Ill) 05/2021 - 01/2020
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 01/2011
2	Hyperplasia 01/2021 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 04/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
12	Messenger RNA (mRNA)IBA 01/2024 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 09/2023 - 03/2014
10	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
8	Circular RNAIBA 01/2021 - 09/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2005
7	CyclinsIBA 01/2019 - 12/2005
7	Rituximab (Mabthera)FDA Link 01/2017 - 10/2008
6	Cyclin D1IBA 01/2023 - 12/2005
5	Transcription Factors (Transcription Factor)IBA 01/2024 - 03/2008
5	Phosphotransferases (Kinase)IBA 01/2019 - 04/2008
4	RNA (Ribonucleic Acid)IBA 11/2023 - 02/2013
4	ParaffinIBA 05/2017 - 05/2012
4	AntibodiesIBA 11/2014 - 04/2002
3	Gemcitabine FDA Link 03/2024 - 01/2012
3	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 04/2008
3	Fluorouracil (Carac)FDA LinkGeneric 03/2023 - 01/2020
3	Competitive Endogenous RNAIBA 01/2023 - 01/2019
3	ChromatinIBA 01/2023 - 10/2009
3	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2014
3	IgKIBA 01/2021 - 08/2006
3	AntigensIBA 01/2021 - 12/2012
3	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 11/2010
3	Cyclin D2IBA 10/2018 - 12/2005
3	Therapeutic UsesIBA 01/2018 - 06/2015
3	Formaldehyde (Formol)FDA Link 05/2017 - 05/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 11/2008
3	squaric acidIBA 01/2017 - 09/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2013 - 11/2008
2	LipidsIBA 04/2024 - 03/2019
2	Interleukin-6 (Interleukin 6)IBA 03/2024 - 10/2023
2	CateninsIBA 01/2024 - 11/2021
2	Histones (Histone)IBA 12/2023 - 10/2012
2	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2018
2	anandamide (arachidonylethanolamide)IBA 04/2023 - 02/2016
2	MutagensIBA 02/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2017
2	venetoclaxIBA 01/2023 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2012
2	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 11/2017
2	Type III Secretion SystemsIBA 01/2022 - 03/2015
2	Long Noncoding RNAIBA 06/2021 - 01/2020
2	Calcibiotic Root Canal SealerIBA 01/2021 - 12/2014
2	Piwi-Interacting RNAIBA 11/2019 - 01/2019
2	B7-H1 AntigenIBA 08/2019 - 05/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 09/2010
2	TensinsIBA 01/2019 - 09/2010

Therapy/Procedure

28	Therapeutics 04/2024 - 12/2004
20	Drug Therapy (Chemotherapy) 03/2024 - 06/2006
5	Immunotherapy 03/2024 - 01/2018
3	Deep Brain Stimulation 01/2022 - 11/2017
2	Radiotherapy 03/2024 - 07/2013
2	Aftercare (After-Treatment) 09/2021 - 05/2017
2	Artificial Respiration (Mechanical Ventilation) 05/2021 - 12/2017
2	Enteral Nutrition (Feeding, Tube) 01/2020 - 12/2017
2	Lasers (Laser) 01/2020 - 01/2020